The trading price of Procept BioRobotics Corp (NASDAQ:PRCT) closed higher on Tuesday, March 04, and closing at $64.98, 7.23% higher than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $103.81 and a 52-week low of $45.56. Over the past month, the stock has lost -10.37% in value.
Procept BioRobotics Corp, whose market valuation is $3.56 billion at the time of this writing, is expected to release its quarterly earnings report in April. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest PRCT has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 50% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned PRCT a recommendation rating is 2. Out of them, 0 rate it a Hold, while 2 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Procept BioRobotics Corp (PRCT) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that PRCT’s price is currently -2.82% off the SMA20 and -12.31% off the SMA50. The RSI metric on the 14-day chart is currently showing 44.14, and weekly volatility stands at 7.73%. When measured over the past 30 days, the indicator reaches 5.72%. Procept BioRobotics Corp (NASDAQ:PRCT)’s beta value is currently sitting at 1.07, while the Average True Range indicator is currently displaying 4.12. With analysts defining $105-$105 as the low and high price targets, we arrive at a consensus price target of $105 for the trailing 12-month period. The current price is about -61.59% off the estimated low and -61.59% off the forecast high, based on this estimate. Investors will be thrilled if PRCT’s share price rises to $105, which is the median consensus price. At that level, PRCT’s share price would be -61.59% below current price.
To see how Procept BioRobotics Corp stock has been performing in comparison to its peers in the industry, here are the numbers: PRCT stock’s performance was 7.23% in the latest trading, and 34.42% in the past year, while Merck & Co. Inc. (MRK) has traded -0.63%% on the day and positioned -24.64% lower than it was a year ago. Another comparable company AbbVie Inc. (ABBV) saw its stock close -1.76%% lower in the most recent trading session but was up 15.96% in a year.
An evaluation of the daily trading volume of Procept BioRobotics Corp (NASDAQ:PRCT) indicates that the 3-month average is 808.91K.
Currently, records show that 54.72 million of the company’s shares remain outstanding. The insiders hold 5.28% of outstanding shares, whereas institutions hold 92.04%. However, since the stock’s price has seen -19.30% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
